Editor-in-Chief
Michael G. Martin, MD, Associate Professor of Medicine, West Cancer Center, Univ. of Tennessee, USA. More...

Frequency: Bimonthly
Journal Access: Open Access

ISSN-print: 1920-4531

ISSN-online: 1920-454X
Indexed and covered: Chemical Abstracts (CA); JournalTOCs; Google Scholar; Elsevier EMBASE; EBSCO; Worldcat; Clarivate Analytics Links- Journal Title List; PubMed Central; PubMed; Scopus, Web of Science (ESCI).
Journal archiving and digital preservation: Portico

Special Issue--call for submissions

COVID-19 in Low Income Countries
COVID-19 has presented novel challenges to health care systems across the world. We at the World Journal of Oncology would like to take a deeper dive into the interaction of COVID-19 and cancer patients across the world. Specifically we are soliciting articles from authors in low income countries. Submission for this special issue with be accepted through October 1st with publication expected on December 1st, 2020. All author fees will be reduced by 50% for this issue. Thank you and we look forward to your submissions. Michael G. Martin, Editor-in-Chief.

Highlights

View Points

Featured

Overexpression of Programmed Death-Ligand 1 Receptor mRNA as an Independent Negative Prognostic Factor for Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) (represents roughly 25% of all breast cancers in Yogyakarta) still has the worst survival compared to other breast cancer subtypes. Results from recent studies have shown that inhibition of programmed death-ligand 1 receptor (PD-L1) in TNBC patients is associated with better prognosis. Full Text

The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab
This case implies that although mogamulizumab has efficacy against T cell lymphomas, the off-target effects of mogamulizumab on T cells normally involved in immune surveillance against virally infected cells can lead to the selective emergence of EBV-positive DLBCL. Administration of this medication requires careful monitoring and surveillance to detect emerging infections and lymphomas. Full Text

Combat the COVID-19

Let's Combat COVID-19 Pandemic Together
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.

Current Issue